Breakdown | ||||
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
5.10B | 3.47B | 3.29B | 2.91B | 2.64B | Gross Profit |
584.70M | 3.47B | 3.29B | 2.91B | 2.64B | EBIT |
1.29B | 254.40M | 360.90M | -21.60M | 294.30M | EBITDA |
-374.60M | -63.40M | 8.30M | 0.00 | -26.60M | Net Income Common Stockholders |
1.03B | 160.80M | 308.70M | -46.10M | 234.10M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
593.30M | 652.50M | 591.80M | 309.50M | 278.50M | Total Assets |
13.67B | 15.10B | 12.81B | 10.59B | 8.87B | Total Debt |
624.90M | 620.70M | 631.90M | 637.20M | 39.40M | Net Debt |
-187.40M | -31.80M | 40.10M | 327.70M | -239.10M | Total Liabilities |
9.78B | 12.53B | 10.68B | 8.78B | 7.25B | Stockholders Equity |
3.88B | 2.57B | 2.13B | 1.81B | 1.63B |
Cash Flow | Free Cash Flow | |||
338.00M | 1.10B | 1.17B | 463.90M | 453.90M | Operating Cash Flow |
393.20M | 1.10B | 1.17B | 476.80M | 460.20M | Investing Cash Flow |
-55.20M | -1.25B | -839.20M | -611.90M | -605.80M | Financing Cash Flow |
-190.80M | 235.70M | -48.00M | 177.80M | 77.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £14.92B | 23.78 | 5.48% | 6.11% | -1.13% | -38.11% | |
80 Outperform | £9.97B | 15.03 | 56.17% | 3.77% | 34.86% | 95.18% | |
79 Outperform | £5.55B | 6.52 | 26.32% | 2.80% | 7.79% | 9.99% | |
63 Neutral | $12.46B | 9.56 | 8.14% | 17044.64% | 12.63% | -4.25% | |
63 Neutral | £3.72B | 25.52 | 5.97% | 2.12% | 26.11% | -29.43% | |
62 Neutral | £5.96B | ― | -60.34% | 8.92% | -6.33% | ― | |
55 Neutral | £13.64B | 81.59 | 4.06% | 8.80% | -21.56% | -61.14% |